Taniwaki, Masafumi, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, and Hiroto Kaneko. “ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING”. Mediterranean Journal of Hematology and Infectious Diseases 10, no. 1 (February 15, 2018): e2018014. Accessed May 31, 2020. https://mjhid.org/index.php/mjhid/article/view/2018.014.